Skip to main content

. 1984 Dec;50(6):837–839. doi: 10.1038/bjc.1984.264

Cytotoxicity of tamoxifen for acute lymphoblastic leukaemia in vitro.

J Blatt, D Rotenstein, S Dienes

PMCID: PMC1977018 PMID: 6594155

837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Danel L., Martin P., Escrich E., Tubiana N., Fière D., Saez S. Androgen, estrogen and progestin binding sites in human leukemic cells. Int J Cancer. 1981 Jun 15;27(6):733–741. doi: 10.1002/ijc.2910270602. [DOI] [PubMed] [Google Scholar]
Kersey J. H., LeBien T. W., Hurwitz R., Nesbit M. E., Gajl-Peczalska K. J., Hammond D., Miller D. R., Coccia P. F., Leikin S. Childhood leukemia-lymphoma. Heterogeneity of phenotypes and prognoses. Am J Clin Pathol. 1979 Oct;72(4 Suppl):746–752. [PubMed] [Google Scholar]
Salomon D. S., Vistica D. T. Steroid receptors and steroid response in cultured L1210 murine leukemia cells. Mol Cell Endocrinol. 1979 Jan;13(1):55–71. doi: 10.1016/0303-7207(79)90076-5. [DOI] [PubMed] [Google Scholar]
Sen L., Borella L. Clinical importance of lymphoblasts with T markers in childhood acute leukemia. N Engl J Med. 1975 Apr 17;292(16):828–832. doi: 10.1056/NEJM197504172921604. [DOI] [PubMed] [Google Scholar]
Stark J. J., Lloyd J. W., Schellhammer P. F. Estrogen receptor activity in a case of Hodgkin's disease. Ann Intern Med. 1981 Aug;95(2):186–187. doi: 10.7326/0003-4819-95-2-186. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES